...$25 million into a $250 million PIPE to fund the deal and are joined by Fidelity Management & Research Co....

...head, inflammation/respiratory.Also participating in the company’s series C were new investors Sofinnova Investments, Longitude Capital, Fidelity Management & Research Co....

...Atlas and OrbiMed, investors in Ikena’s round included Fidelity Management & Research Co....

...series B round led by GV, with backing from existing investors Polaris Partners, Mithril Capital, Fidelity Management & Research Co....

...immunotherapies made using synthetic DNA to incorporate non-native amino acids into proteins. New investors included Fidelity Management & Research Co....

...round led by OrbiMed Advisors and an undisclosed existing investor, with participation from new investor Fidelity Management & Research Co....

...therapy programs into the clinic and build a commercially scalable GMP manufacturing facility. Led by Fidelity Management & Research Co....

...Shanghai cancer company Antengene Corp. raised $97 million in a series C round led by Fidelity Management & Research Co....

...newco aims to produce up to 60 million doses per year from one 100,000-liter reactor. Fidelity Management & Research Co....

...program into the clinic. RA Capital led the round, which saw participation from new investors Fidelity Management & Research Co....